These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1321608)

  • 1. Invasion of brain tissue by primary glioma: evidence for the involvement of urokinase-type plasminogen activator as an activator of type IV collagenase.
    Reith A; Rucklidge GJ
    Biochem Biophys Res Commun; 1992 Jul; 186(1):348-54. PubMed ID: 1321608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of urokinase-type plasminogen activator (u-PA) and plasminogen activator inhibitor-1 (PAI-1) in human brain tumours.
    Arai Y; Kubota T; Nakagawa T; Kabuto M; Sato K; Kobayashi H
    Acta Neurochir (Wien); 1998; 140(4):377-85; discussion 385-6. PubMed ID: 9689330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and interrelationships of the multiple molecular tissue-type and urokinase-type plasminogen activator forms produced by cultured human umbilical vein endothelial cells.
    Booyse FM; Scheinbuks J; Lin PH; Traylor M; Bruce R
    J Biol Chem; 1988 Oct; 263(29):15129-38. PubMed ID: 3139666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human glioma U-251 cells contain type 1 plasminogen activator inhibitor in a rapidly releasable form.
    Salonen EM; Gombau L; Engvall E; Schleef RR
    FEBS Lett; 1996 Sep; 393(2-3):216-20. PubMed ID: 8814293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolytic processing of the 72,000-Da type IV collagenase by urokinase plasminogen activator.
    Keski-Oja J; Lohi J; Tuuttila A; Tryggvason K; Vartio T
    Exp Cell Res; 1992 Oct; 202(2):471-6. PubMed ID: 1397099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
    Allan EH; Martin TJ
    J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane-associated procollagenase of leukemic cells is activated by urokinase-type plasminogen activator.
    Santibañez JF; Martínez J
    Leuk Res; 1993 Dec; 17(12):1057-62. PubMed ID: 8246609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.
    Stephens RW; Pöllänen J; Tapiovaara H; Leung KC; Sim PS; Salonen EM; Rønne E; Behrendt N; Danø K; Vaheri A
    J Cell Biol; 1989 May; 108(5):1987-95. PubMed ID: 2523891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation.
    Quax PH; van Muijen GN; Weening-Verhoeff EJ; Lund LR; Danø K; Ruiter DJ; Verheijen JH
    J Cell Biol; 1991 Oct; 115(1):191-9. PubMed ID: 1918136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
    Sitter T; Toet K; Quax P; Kooistra T
    Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation.
    Brommer EJ; Dooijewaard G; Dijkmans BA; Breedveld FC
    Thromb Haemost; 1992 Aug; 68(2):180-4. PubMed ID: 1412164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoic acid modulates extracellular urokinase-type plasminogen activator activity in DU-145 human prostatic carcinoma cells.
    Waghray A; Webber MM
    Clin Cancer Res; 1995 Jul; 1(7):747-53. PubMed ID: 9816041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fibrinolytic system in neoplasia.
    Bell WR
    Semin Thromb Hemost; 1996; 22(6):459-78. PubMed ID: 9122711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serpin inhibitors of urokinase and thrombin in normal rat brain and the 9L brain tumor: evidence for elevated expression of protease nexin I-like inhibitor and a novel sodium dodecyl sulfate-activated tumor antithrombin.
    Rao JS; Baker JB; Morantz RA; Kimler B; Evans R; Festoff BW
    Cancer Res; 1990 Aug; 50(16):5039-44. PubMed ID: 2116223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin induction of tissue plasminogen activator expression in corneal endothelial cells in vitro.
    Ramsby ML; Kreutzer DL
    Invest Ophthalmol Vis Sci; 1993 Oct; 34(11):3207-19. PubMed ID: 7691778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activator activity is decreased in rat gingiva during diabetes.
    Chang K; Rani AS; Chang K; Kumar S
    J Periodontol; 1996 Aug; 67(8):743-47. PubMed ID: 8866312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells--role in metastasis.
    Salo T; Liotta LA; Keski-Oja J; Turpeenniemi-Hujanen T; Tryggvason K
    Int J Cancer; 1982 Nov; 30(5):669-73. PubMed ID: 6295970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
    Collen D; De Cock F; Demarsin E; Lijnen HR; Stump DC
    Thromb Haemost; 1986 Aug; 56(1):35-9. PubMed ID: 3095946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro effects of interleukin 1 on the synthesis of metalloproteases, TIMP, plasminogen activators and inhibitors in human articular cartilage.
    Martel-Pelletier J; Zafarullah M; Kodama S; Pelletier JP
    J Rheumatol Suppl; 1991 Feb; 27():80-4. PubMed ID: 1851231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.